Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
23847studies shown
Showing 17,869-17,880 of 23,847
Device study icon
CompletedNCT01590862

ON/OFF Stimulation and Reward Motivation in people with Deep Brain Stimulators

This study exists to see whether a digital app or remote support tool can make care clearer and more responsive. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.

Multiple locations, including Boston
Depression, OCDDeviceA study involving a tool, app, wearable, test, or medical device.From 18 Years to 70 Years
Countries
United States
Sponsor
Massachusetts General Hospital
Condition
Depression, OCD
Drug study icon
WithdrawnNCT00964041

Once Weekly D-cycloserine for Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In Boston
SchizophreniaDrugA study involving a medication or substance.From 18 Years to 65 Years
Countries
United States
Sponsor
Massachusetts General Hospital
Condition
Schizophrenia
Drug study icon
CompletedNCT01549041

Once-Daily Asenapine for Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In Butner
SchizophreniaDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
Duke University
Condition
Schizophrenia
Behavioral study icon
CompletedNCT01303536

Ondansetron Augmentation in Treatment-resistant OCD

This summary needs review. Please check the official study record and contact the research team for details.

In Florence
OCDBehavioralFrom 18 Years to 60 Years
Countries
Italy
Sponsor
Institute of Neuroscience, Florence, Italy
Condition
OCD
Behavioral study icon
CompletedNCT02082678

Ondansetron for Bipolarity and Alcohol Use Disorders

This study exists to explore whether a therapy or guided support program could improve care and understanding. Researchers are trying to understand whether a therapy or guided support program can improve attention, thinking, or day-to-day functioning.

In Dallas
Bipolarity, AddictionBehavioralFrom 18 Years to 70 Years
Countries
United States
Sponsor
University of Texas Southwestern Medical Center
Condition
Bipolarity, Addiction
Drug study icon
CompletedNCT00796497

Ondansetron in Treatment Resistant OCD (OCD)

This summary needs review. Please check the official study record and contact the research team for details.

In Florence
OCDDrugFrom 18 Years to 55 Years
Countries
Italy
Sponsor
Institute of Neuroscience, Florence, Italy
Condition
OCD
Drug study icon
TerminatedNCT01113541

One-Year study of Oral Ziprasidone in Bipolar people with Metabolic Syndrome

This study exists to explore whether the medication Oral could improve care and understanding. Researchers are trying to understand how people respond to the medication Oral in practice and what may need to be adjusted.

Multiple locations, including Calgary
BipolarityDrugFrom 18 Years to 65 Years
Countries
Canada
Sponsor
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Condition
Bipolarity
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.